top of page
it's where dermatology lives
Allan Ryan
Nov 18, 20242 min read
SARS-COV-2 mRNA vaccines improve clinical responses to immune checkpoint inhibition
In a new study, researchers have identified benefits of SARS-COV-2 mRNA vaccines for cancer patients undergoing immunotherapy. The...
Allan Ryan
Apr 8, 20242 min read
Modulating the gut microbiome may improve response to ICB therapy
Deciphering and modifying the composition of various gut bacteria may improve immune checkpoint blockade (ICB) treatment responses in...
Allan Ryan
Jun 5, 20232 min read
Researchers investigate why some skin cancers stop responding to therapy at end of life
Changes in the order, structure, and number of copies of tumour DNA could be the reason some skin cancers ultimately resist treatment,...
John Evans
Nov 18, 20221 min read
Nivolumab shows promise in advanced cutaneous squamous cell carcinoma
Findings from a recent phase II clinical trial show promising results for the immune checkpoint inhibitor nivolumab in the treatment of...
John Evans
Jan 14, 20222 min read
Skin reactions may show efficacy of immune checkpoint inhibitors
New findings suggest the development of cutaneous immune-related adverse events (cirAEs) is associated with better treatment efficacy and...
John Evans
Jan 7, 20222 min read
Combination LAG-3/PD-1 inhibition superior to PD-1 inhibition monotherapy for metastatic melanoma
Findings from a new study suggest that inhibiting both the LAG-3 and PD-1 immune checkpoints in patients with previously untreated...
Cory Perla
Apr 14, 20211 min read
VIDEO: Study finds 10 skin-related conditions associated with immune checkpoint inhibitors
An analysis of real-world data has evaluated the incidence, type and severity of skin-related side effects of immune checkpoint inhibitors.
Featured Posts
bottom of page